Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Paul N. Hopkins, University of Utah
ClinicalTrials.gov Identifier:
NCT01328769
First received: March 29, 2011
Last updated: December 9, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)